Mild Cognitive Impairment
Mild Cognitive Impairment (MCI) is a neurocognitive disorder characterized by cognitive impairments that surpass normal age-related changes but do not interfere with daily living activities, serving as a potential transitional stage between normal aging and dementia, including Alzheimer's disease. This condition includes both memory and non-memory impairments, with unclear causes, prevention, and treatment, and about 50 percent of those diagnosed progressing to Alzheimer's within five years.
Health Outcomes
- Improved Alzheimer Disease Assessment Scale-Cognitive Subscale Score
- Improved Analytical Accuracy
- Improved Attention Score
- Improved Brain Function
- Improved Brain Health
- Improved Brain-Derived Neurotrophic Factor Level
- Improved Central Nervous System Function
- Improved Cerebral Blood Flow Velocity
- Improved Cognition
- Improved Cognitive Accuracy
- Improved Cognitive Behavior
- Improved Cognitive Development
- Improved Cognitive Flexibility
- Improved Cognitive Function
- Improved Cognitive Functioning
- Improved Cognitive Orientation Function
- Improved Cognitive Performance
- Improved Cognitive Prognosis
- Improved Cognitive Reaction Time
- Improved Cognitive Score
- Improved Cognitive Screen Score
- Improved Cognitive Speed
- Improved Cognitive Stabilization
- Improved Cognitive Subdomain
- Improved Communication
- Improved Decision Accuracy
- Improved Decision-Making Accuracy
- Improved Delayed Memory
- Improved Delayed Word Recall
- Improved Episodic Memory
- Improved Focus
- Improved Global Cognition
- Improved Healthy Aging
- Improved Hippocampal Fractional Anisotropy
- Improved Immediate Memory
- Improved Learning
- Improved MMSE Score
- Improved Mathematical Processing
- Improved Memory Function
- Improved Memory Performance
- Improved Memory Response to Tetanus Toxoid Antigen
- Improved Mini-Mental State Examination Score
- Improved Neurobehavioral Function
- Improved Neuroplasticity Biomarkers
- Improved Neurotrophic Signaling
- Improved Orientation in Time (MMSE Subscale)
- Improved Pattern Separation
- Improved Performance Developmental Score
- Improved Performance Mastery
- Improved Processing Speed
- Improved Reaction Time
- Improved Recognition Memory
- Improved Set-Shifting Reaction Time
- Improved Short-term Memory
- Improved Simon Task Accuracy
- Improved Simulated Game Total Completion Time
- Improved Spatial Learning Ability
- Improved Speed Score
- Improved Strategic Efficiency
- Improved Telephone Interview for Cognitive Status Score
- Improved Visual-Spatial Function
- Improved Visuo-Cognitive Processing
- Improved Working Memory
- Improved Working Memory Reaction Time
- Increased Brain Choline Level
- Increased DHA Level
- Increased Neurogenesis
- Increased Prefrontal Cortex Deoxygenated Hemoglobin Level
- Maintained Cognitive Function
- Maintained or Improved Cognitive Function
- Modified Resting-State Brain Connectivity
- No Significant Cognitive Improvement
- No Significant Improvement in Memory Retention
- Reduced Alzheimer’s Disease Pathology
- Reduced Brain Atrophy
- Reduced Cognitive Decline
- Reduced Cognitive Function
- Reduced Cognitive Impairment
- Reduced Confusion and Bewilderment
- Reduced Folate Deficiency
- Reduced Prefrontal Cortex Oxygenated Hemoglobin
- Reduced Prefrontal Cortex Total Hemoglobin Level
- Reduced Psychological Score
- Reduced Response Time on Flanker Task
- Reduced Retroactive Interference
- Reduced Subjective Cognitive Decline
- Restored Neurodegeneration-Associated Metabolic Alterations